Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Data & Figures
Ordering
Resources
hTERT ICC Test
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
Publications
Heading &
Sub-heading can be edited through HQI
Technology
>
Publications
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Publications
Please
contact us
for further information about any of the key publications:
BARD1
Magdalena Ratajska, Magalena Matusiak, Alina Kuzniacka, Bartosz Wasag, Izabela Brozek, Wojciech Biernat, Magdalena Koczkowska, Jaroslaw Debniak, Marcin Sniadecki, Piotr Kozlowski, Katarzyna Klonowska, Maxim Pilyugin, Dariusz Wydra, Geoff Laurent, Janusz Limon, Irmgard Irminger-Finger.
Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoform
s
.
Oncol Rep. (November 2015);34(5):2609-17.
Pierre-Alain André, Cecilia Prêle, Sarah Vierkotten, Stéphanie Carnesecchi, Yves Donati, Rachel C Chambers, Jean-Claude Pache, Bruno Crestani, Constance Barazzone-Argiroffo, Melanie Königshoff, Geoffrey J Laurent, Irmgard Irminger-Finger.
BARD1 mediates TGF-β signaling in pulmonary fibrosis
. Respir Res. (29 September 2015);16:118.
Irmgard Irminger-Finger, Magda Ratajska, Maxim Pilyugin.
New concepts on BARD1: Regulator of BRCA pathways and beyond
. Int J Biochem Cell Biol. (March 2016);72:1-17.
Kamila A Marzec, Estefania Martino-Echarri, Irmgard Irminger-Finger, Beric R Henderson.
BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin
. Cancer Lett. (28 July 2016);381(1):149-155.
hTERT
Derek B Allison, Rajni Sharma, Morgan L Cowan, Christopher J VandenBussche.
Evaluation of Sienna Cancer Diagnostics hTERT antibody on 500 consecutive urinary tract specimens
. Acta Cytologica (2018), DOI: 10.1159/000489181.
Poster Presentation:
M Lalla, Christopher J VandenBussche, G Huan, P Anderson.
The hTERT ICC Test as an Adjunct to Urine Cytology: A Longitudinal Follow-Up
. Presented at ICC 2020: 22
nd
International Conference on Cytology London, United Kingdom (21-22 May 2020).
NET
s
Carlos Salomon
,
Saumya Das
,
Uta Erdbrügger
,
Raghu Kalluri
,
Sai Kiang Lim
,
Jerrold M Olefsky
,
Gregory E Rice
,
Susmita Sahoo
,
W Andy Tao
,
Pieter Vader
,
Qun Wang
,
Alissa M
Weaver.
Extracellular Vesicles and Their Emerging Roles as Cellular Messengers in Endocrinology: An Endocrine Society Scientific Statement
.
Endocrine Reviews (June 2022).
Poster Presentation:
Thomas Stewart, Tamkin Ahmadzada, Sophia Amerena-Cowie, Emily Stein, Peter French, Gregory Rice, Michelle Wood, Joonsup Lee, Elham Hosseini-Beheshti, Peter A Lay, Georges E Grau.
Differential detection of cancer-derived extracellular vesicles using combined antibody functionalized magnetic beads and infrared spectroscopy
.
Poster Presentation:
Andrew Lai, Dominic Guanzon, Carlos Palma, Ramin Khanabdali, Lewis Perrin, John Hooper, Jim Coward, Gregory Rice, Carlos Salomon.
Reproducibility and efficiency of an extracellular vesicle capture technology for the detection of ovarian cancer
. Presented at ISEV Conference in Seattle, USA (18 May 2023).
Poster Presentation:
Olesia Gololobova, Gregory Rice, Ramin Khanabdali, Kenneth W. Witwer.
Enrichment of extracellular vesicles from human plasma with molecular net matrix coated magnetic beads (EXO-NET®)
. Presented at ISEV Conference in Seattle, USA (19 May 2023).
Poster Presentation:
Ramin Khanabdali, Carlos Palma, Sara Nikseresht, Siena Barton, Khairul Ansari, Sukhdeep Spall, Laura F Dagley, Susan Belzer, Gregory Rice
.
High-throughput isolation and enrichment of extracellular vesicles using an immunoaffinity magnetic bead-based matrix
. Presented at ISEV Conference in Seattle, USA (19 May 2023).
Poster Presentation:
Ramin Khanabdali
,
Chun Liu, Carlos Palma, Saso Ivanovski, Pingping Han, Gregory Rice
.
EXO-NET enriched salivary extracellular vesicles in periodontitis
. Presented at ISEV Conference in Seattle, USA (20 May 2023).
SubB2M
Christopher J Day, Adrienne W Paton, Melanie A Higgins, Lucy K Shewell, Freda E-C Jen, Benjamin L Schulz, Brock P Herdman, James C Paton, Michael P Jennings (2017).
Structure aided design of a Neu5Gc specific lectin
. Nature Scientific Reports; 7: 1495
Jing Wang, Lucy K Shewell, Adrienne W Paton, James C Paton, Christopher J Day, Michael P Jennings (2018).
Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin
. Biochemical and Biophysical Research Communications 500: 765-771
Lucy K Shewell, Jing Wang, James C Paton, Adrienne W Paton, Christopher J Day, Michael P Jennings (2018).
Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M
. Biochemical and Biophysical Research Communications 507: 173-177.
Lucy K Shewell, Christopher J Day, Jamie R Kutasovic, Jodie L Abrrahams, Jing Wang, Jessica Poole, Colleen Niland, Kaltin Ferguson, Jodie M Saunus, Sunil R Lakhani, Mark von Itzstein, James C Paton, Adrienne W Paton, Michael P Jennings.
N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
.
bioRxiv (preprint August 2021).
Poster Presentation:
Ramin Khanabdali, Sara Nikseresht, Khairul Ansari, and Gregory Rice.
Tumor-derived extracellular vesicles enrichment using a novel immunoaffinity magnetic bead-based matrix
. Presented at ISEV Conference in Seattle, USA (19 May 2023).